Generics Bidco II LLC d/b/a Prinston Laboratories
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3700A Woodpark Blvd., Charlotte, North Carolina (NC) 28206, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 1038197 · DUNS 968329537
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-19
- NAIDrug Quality Assurance2020-03-11
- NAIDrug Quality Assurance2018-07-13
- NAIDrug Quality Assurance2016-08-24
- NAIDrug Quality Assurance2015-04-09
- NAIDrug Quality Assurance2014-05-07
- OAIDrug Quality Assurance2014-02-14
- NAIDrug Quality Assurance2012-08-10
- NAIDrug Quality Assurance2011-06-09
- NAIDrug Quality Assurance2010-04-15
Drugs this plant is listed as making
2 distinct drugs across 8 products name this site in their FDA label.
- perphenazineEndo USA, Inc.
- phenobarbitalPar Health USA, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.